[1594] Different Predilection of the Anatomic Distribution of Extra-Lymphoid Involvement in T-Lymphoblastic Lymphoma and B-Lymphoblastic Lymphoma of Childhood
Micah Will, Liqun Yin, Xiayuan Liang. University of Colorado Denver School of Medicine, Aurora, CO
Background: Lymphoblastic lymphoma (LBL) is relatively uncommon compared to lymphoblastic leukemia. LBL may exist with or without a leukemic phase and in some cases may present with extra-lymphoid involvement. Extra-lymphoid presentation may cause a diagnostic challenge if it is not suspected as the differential diagnosis for small round blue cell tumors in children is broad. The characteristic distribution of extra-lymphoid involvement of LBL has not been fully elucidated. We examined a series of pediatric patients with LBL between 1991 and 2011 at our institution.
Design: 43 cases of LBL (23 B-LBL and 20 T-LBL) at Children's Hospital CO were evaluated. All patients were < 20 years of age. Extra-lymphoid involvement is defined as the presence of a tumor mass or tumor cells outside lymph nodes, thymus, spleen, or tonsils. Bone marrow (BM) and cerebrospinal fluid (CSF) involvement was counted separately from extra-lymphoid involvement. The differences of age, sex, and anatomic distribution of extra-lymphoid tumors are compared between B-LBL and T-LBL.
Results: 1) B-LBL tended to occur in the head, bone, and BM more frequent than T-LBL. 2) T-LBL tended to involve body cavities (pleural/pericardial effusion and CSF) and GU system more often than B-LBL. Due to small sample size, only the difference in pleural/pericardial effusion and BM involvement reached statistical significance (p = 0.0183 and p = 0.0281).
| B-LBL | T-LBL | p value | ||
| # of cases | 23 | 20 | ||
| Mean age (y) | 9.3 | 11.3 | 0.2288* | |
| M:F | 14:9 | 16:4 | 0.1517♠ | |
| Extra-lymphoid involvement | 14/22 (63.6%) | 9/20 (45.0%) | 0.1001♠ | |
| Head | 5/14 (35.7%) | 1/9 (11.1%) | 0.2082♠ | |
| Bone | 5/14 (36.7.8%) | 0/9 (0%) | 0.0595♠ | |
| Soft tissue | 3/14 (21.4%) | 1/9 (11.1%) | 0.4830♠ | |
| Breast | 1/14 (7.1%) | 1/9 (11.1%) | 0.6403♠ | |
| GU | 1/14 (7.1%) | 3/9 (33.3%) | 0.1470♠ | |
| GI | 1/14 (7.1%) | 0/9 (0%) | 0.6087♠ | |
| Skin | 2/14 (14.3%) | 1/9 (11.1%) | 0.6680♠ | |
| Pleural/pericardial effusion | 1/14 (7.1%) | 5/9 (55.6%) | 0.0183♠ | |
| BM+ | 13/20 (65.0%) | 6/20 (30.0%) | 0.0281♠ | |
| CSF+ | 2/21 (9.5%) | 4/20 (20%) | 0.3073♠ |